Allogene Therapeutics, Inc. short interest in 2021
In 2021, Allogene Therapeutics, Inc.'s disclosed short interest ran from 9.78% of shares outstanding on 15 Jan 2021 to 5.32% on 31 Dec 2021, a change of -4.46 percentage points. The year's high was 9.78% on 15 Jan 2021 and its low 3.32% on 15 Oct 2021, averaging 5.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.76 days on 12 Feb 2021. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 9.78% (15 Jan 2021)
- End of year
- 5.32% (31 Dec 2021)
- Change
- -4.46 pp
- High
- 9.78% (15 Jan 2021)
- Low
- 3.32% (15 Oct 2021)
- Average
- 5.93%
- Highest days to cover
- 19.76 (12 Feb 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 9.78% | 18.12 | |
| 29 Jan 2021 | 8.22% | 13.63 | |
| 12 Feb 2021 | 7.90% | 19.76 | |
| 26 Feb 2021 | 8.23% | 19.54 | 10-K filed, results (8-K) |
| 15 Mar 2021 | 7.33% | 9.50 | |
| 31 Mar 2021 | 6.15% | 11.18 | |
| 15 Apr 2021 | 5.92% | 13.82 | |
| 30 Apr 2021 | 5.17% | 11.94 | |
| 14 May 2021 | 5.82% | 8.79 | 10-Q filed, results (8-K) |
| 28 May 2021 | 5.62% | 3.39 | |
| 15 Jun 2021 | 5.78% | 7.00 | |
| 30 Jun 2021 | 6.69% | 5.28 | |
| 15 Jul 2021 | 6.70% | 10.79 | |
| 30 Jul 2021 | 6.55% | 18.62 | |
| 13 Aug 2021 | 5.89% | 12.30 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 5.87% | 10.29 | |
| 15 Sep 2021 | 5.52% | 13.65 | |
| 30 Sep 2021 | 5.61% | 10.72 | |
| 15 Oct 2021 | 3.32% | 1.00 | |
| 29 Oct 2021 | 3.34% | 3.55 | |
| 15 Nov 2021 | 3.98% | 3.92 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 3.77% | 5.99 | |
| 15 Dec 2021 | 3.95% | 3.49 | |
| 31 Dec 2021 | 5.32% | 5.80 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.